COMMUNIQUÉS West-GlobeNewswire

REVA Continues Suspension Of Trading
12/03/2019
SAN DIEGO, March 12, 2019 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX: RVA) (“REVA” or the “Company”) voluntarily suspended trading on 24 February 2019 while in discussions with representatives of certain major debt and [...]
Fine Arts Skin & Laser Hold Event to Benefit a Local Domestic Violence Shelter
12/03/2019
Join plastic surgeon Dr. David Hartman and his team on March 14 for Girls’ Night for Good 2.0 DOVER, Ohio, March 12, 2019 (GLOBE NEWSWIRE) -- Building on the success of 2018’s successful pampering-focused charity event [...]
8 Tips to Help Prevent Rosacea Flare-Ups; American Academy of Dermatology
12/03/2019
ROSEMONT, Ill., March 12, 2019 (GLOBE NEWSWIRE) -- Rosacea is a common skin condition that causes redness to form across the nose and cheeks. According to dermatologists from the American Academy of Dermatology, [...]
Altimmune Announces Closing of $14 Million Registered Direct Offering
12/03/2019
GAITHERSBURG, Md., March 12, 2019 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage immunotherapeutics company, today announced the closing of the previously announced registered direct offering of [...]
DiaMedica Therapeutics to Attend 31st Annual ROTH Investor Conference on March 18-19, 2019
12/03/2019
MINNEAPOLIS, March 12, 2019 (GLOBE NEWSWIRE) -- DiaMedica Therapeutics Inc. (Nasdaq: DMAC) today announced that it will be attending the 31 st Annual ROTH Conference March 18-19, 2019, at The Ritz Carlton, Laguna Niguel [...]
Monthly information related to total number of voting rights and shares composing the share capital – February 28, 2019
12/03/2019
LYON, France, March 12, 2019 (GLOBE NEWSWIRE) -- Article 223-16 of general regulation of French Autorité des Marchés Financiers Lyon - France Listing markets: Euronext Paris from Euronext (Market segment C - ISIN Code: [...]
Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social – 28 Février 2019
12/03/2019
LYON, France, 12 mars 2019 (GLOBE NEWSWIRE) -- Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers Lyon - France Places de cotation : Euronext Paris de Euronext (Compartiment C - Code ISIN : [...]
Notice to Convene Annual General Meeting 2019
12/03/2019
Company Release no. 03/2019 To: NASDAQ Copenhagen A/S Copenhagen, Denmark, 12 March 2019 Notice to Convene Annual General Meeting 2019 The board of directors of Veloxis Pharmaceuticals A/S, CVR no. 26 52 77 67 ("the [...]
Crown Bioscience Inc. et Charles River Laboratories concluent un accord visant à élargir l'accès au modèle de rat ZDSD
12/03/2019
L'accord permet une plus grande disponibilité du modèle mondial pour la découverte de médicaments dans le traitement de l'obésité, du diabète et du syndrome métabolique SAN DIEGO, Californie et WILMINGTON, Massachusetts [...]
CalvertHealth Partners with North American Partners in Anesthesia
12/03/2019
MELVILLE, N.Y., March 12, 2019 (GLOBE NEWSWIRE) -- North American Partners in Anesthesia (NAPA) , one of the leading single-specialty anesthesia and perioperative management companies in the US, welcomes the anesthesia [...]
Nurse-Family Partnership Unveils Parent Ambassador Program
12/03/2019
Introducing six NFP graduates who will travel the country telling their stories and advocating for Nurse-Family Partnership DENVER, March 12, 2019 (GLOBE NEWSWIRE) -- One woman learned she was pregnant just before her [...]
Herantis Pharma Plc Announces Positive Outcome of Directed Share Issue Raising EUR 5.8 Million
12/03/2019
Herantis Pharma Plc Announces Positive Outcome of Directed Share Issue Raising EUR 5.8 Million Herantis Pharma Plc Company release 12 March 2019, 5:00 pm Not for publication or distribution, directly or indirectly, in [...]
bioAffinity Technologies Announces Formation of Scientific and Medical Advisory Board; M. Patricia Rivera, MD, Joins Board as Chair
12/03/2019
SAN ANTONIO, March 12, 2019 (GLOBE NEWSWIRE) -- bioAffinity Technologies , a privately held biotech company, today announced the formation of a Scientific and Medical Advisory (SMA) Board to provide independent expert [...]
XORTX Signs LOI for Co-Development and Licensing Agreement with Japan’s Teijin Pharma Limited
12/03/2019
Phase 2B Clinical Study in Diabetic Nephropathy Planned in 2019 CALGARY, Alberta, March 12, 2019 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (" XORTX " or the “ Company ”) (CSE: XRX; OTCQB: XRTXF), a biopharmaceutical [...]
Huron Digital Pathology Connects Pathologists, Researchers and Educators to the Expertise of their Colleagues with New ‘Scan Index Search’ Platform
12/03/2019
Company to showcase new high capacity, intelligent slide scanner and AI-powered image search engine at USCAP 2019 St. Jacobs, ON, Canada, March 12, 2019 (GLOBE NEWSWIRE) -- At the upcoming USCAP 2019 conference in [...]
Introducing OnMed: The First Interactive Telemedicine Station to Diagnose Patients and Dispense Prescription Meds in Real Time
12/03/2019
Health technology company providing affordable access to quality care announces the international launch of its remote consultation technology CLEARWATER, Fla., March 12, 2019 (GLOBE NEWSWIRE) -- OnMed ® , an innovative [...]
Nemaura Medical Announces Exclusive License and Supply Agreement for SugarBEAT® in the GCC Region
12/03/2019
Loughborough, England , March 12, 2019 (GLOBE NEWSWIRE) -- Loughborough, England – March 12, 2019 – Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company focused on the development of SugarBEAT® as a non- [...]
Better Choice Company Announces Launch of 9 New CBD Product SKUs
12/03/2019
NEW YORK, March 12, 2019 (GLOBE NEWSWIRE) -- Better Choice Company, Inc (OTCQB: BTTR) (OTC QB: SENZ) (the “Company”) today announced the launch of 9 new hemp-based canine cannabidiol (“CBD”) product SKUs as the [...]
Bio-Path Holdings, Inc. Announces $18.5 Million Registered Direct Offering of Common Stock
12/03/2019
HOUSTON, March 12, 2019 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (Nasdaq: BPTH) (Bio-Path), a biotechnology company leveraging its proprietary DNAbilize® antisense RNAi nanoparticle technology to develop a portfolio [...]

Pages